Literature DB >> 12538194

Nitrous oxide and xenon inhibit the human (alpha 7)5 nicotinic acetylcholine receptor expressed in Xenopus oocyte.

Takahiro Suzuki1, Kazuyoshi Ueta, Masahiro Sugimoto, Ichiro Uchida, Takashi Mashimo.   

Abstract

The neuronal nicotinic acetylcholine (nACh) receptor is one of the ligand-gated ion channels that regulate the synaptic release of neurotransmitters in the central nervous system. Recently, neuronal nACh receptors have received attention as a potential target for general anesthetics because many general anesthetics inhibit their functions at clinical concentrations. Several general anesthetics are known to inhibit the homomeric (alpha(7))(5) nACh receptor, a subtype of neuronal nACh receptors, but the effects of two gaseous anesthetics, nitrous oxide (N(2)O) and xenon (Xe), remain unknown. Using the two-electrode voltage-clamping technique, we investigated the effects of N(2)O and Xe at the human (alpha(7))(5) nACh receptor expressed in Xenopus oocytes. At clinically relevant concentrations, N(2)O and Xe reversibly inhibited the ACh-induced currents of the (alpha(7))(5) nACh receptor in a concentration-dependent manner. The inhibitory actions of both anesthetics at the (alpha(7))(5) nACh receptor were noncompetitive and voltage-independent. Our results suggest that inhibition of the (alpha(7))(5) nACh receptor by N(2)O and Xe may play a role in their anesthetic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538194     DOI: 10.1097/00000539-200302000-00028

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

1.  N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas.

Authors:  Kellianne J Richardson; Keith L Shelton
Journal:  J Pharmacol Exp Ther       Date:  2014-11-03       Impact factor: 4.030

2.  Tau Protein Levels in ADHD.

Authors:  Keith Fluegge
Journal:  Indian J Clin Biochem       Date:  2018-04-19

3.  The BTBR mouse model, cholinergic transmission, and environmental exposure to nitrous oxide.

Authors:  Keith Fluegge
Journal:  Psychopharmacology (Berl)       Date:  2016-10-08       Impact factor: 4.530

4.  Isoflurane suppresses stress-enhanced fear learning in a rodent model of post-traumatic stress disorder.

Authors:  Vinuta Rau; Irene Oh; Michael Laster; Edmond I Eger; Michael S Fanselow
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

Review 5.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

6.  A model of lipid dysregulation and altered nutrient status in Alzheimer's disease.

Authors:  Keith Fluegge
Journal:  Alzheimers Dement (N Y)       Date:  2019-04-30

7.  Xenon impairs reconsolidation of fear memories in a rat model of post-traumatic stress disorder (PTSD).

Authors:  Edward G Meloni; Timothy E Gillis; Jasmine Manoukian; Marc J Kaufman
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

8.  A reply to 'Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study'.

Authors:  K Fluegge
Journal:  Transl Psychiatry       Date:  2016-04-26       Impact factor: 6.222

9.  Zinc and Copper Metabolism and Risk of Autism: a reply to Sayehmiri et al.

Authors:  Keith Fluegge Ba
Journal:  Iran J Child Neurol       Date:  2017

Review 10.  Update of the organoprotective properties of xenon and argon: from bench to beside.

Authors:  Roehl Anna; Rossaint Rolf; Coburn Mark
Journal:  Intensive Care Med Exp       Date:  2020-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.